5th exec joins Moderna billionaire club — as stock price soars despite growing number of injury reports
For the fifth time since the onset of the COVID pandemic in early 2020, the skyrocketing price of Moderna stock has produced a billionaire, but the vaccine is coming under increasing scrutiny for possible links to blood clots and heart inflammation.
•